EVALUATION OF CHEMOTHERAPEUTIC AGENT AMONG BREAST CANCER RECEIVING CHEMOTHERAPY; AN OBSERVATION PROSPECTIVE STUDY
Fatemeh Dianatinasab,*, U. R. Rakshith and M. S. Vishveshwara
ABSTRACT
Objectives: This hospital based case study was undertaken with aim to evaluation of chemotherapeutic agents in management of carcinoma management of breast in oncology specialized hospital. the objective of this study was to assess prescribing patterns of breast cancer and to determine rational use and appropriate choice of chemotherapevlic aged is depends on type and grade of cancer and also patient specific characteristic according to NCC guideline and EVIQ guideline. Methods: The study was a prospective observational study which was carried for a period of 6 months in Bharath Hospital in patients with breast cancer receiving chemotherapy. Most of the patient details were collected from patient case sheets or laboratory reports. A total of 100 patients who were receiving anti-cancer agent as either adjuvant or neoadjuvant therapy for breast cancer followed during 6 month of study period. In this study appropriateness/ inappropriateness of chemotherapy regimen were reviewed base on their indicated stage, dose, route, and frequency duration of administration. Results: the result of study found inappropriate as per NCCN and EVIQ guideline. Conclusion: based on current findings, it can be suggested that uses of anti-emetic drugs need further improvement in terms of frequency and choice of drug in many cases. Education and training program to nursing staff would certainly help to improvise the delivery of chemotherapy.
Keywords: Chemotherapy, Drug utilization, Endocrine therapy.
[Full Text Article]
[Download Certificate]